Home  /  Resource Library  /  Assessment of Tumor Lysis Syndrome in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax in the Clinical Trial and Post-Marketing Settings

Assessment of Tumor Lysis Syndrome in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax in the Clinical Trial and Post-Marketing Settings

ASH 2020: Pooled analysis examined the incidence of tumor lysis syndrome in patients with CLL treated with ventoclax.